TGFB1 and tuberculosis: A small subset of cases was followed longitudinally to observe the changes in plasma expression of measured analytes (sMAdCAM, sICAM, sVCAM, LBP, TGF-β1, TGF-β2 and TGF-β3) in response to TB treatment completion in the TRuTH cohort (n=14).